Search results for " Allergic"

showing 10 items of 182 documents

Exhaled Nitric Oxide and Bronchial Responsiveness to Adenosine 5′-Monophosphate in Subjects With Allergic Rhinitis

2002

Study objectives: To determine differences in exhaled nitric oxide (ENO) between subjects with allergic rhinitis with and without increased responsiveness to direct and indirect bronchoconstrictor agents. Study design: Cross-sectional study with the order of challenge tests randomized. Setting: Specialist allergy unit in a university hospital. Patients: Thirty-eight subjects without asthma with allergic rhinitis and 10 healthy nonatopic control subjects. Measurements and results: Participants were challenged with increasing concentrations of adenosine 5monophosphate (AMP) and methacholine. ENO was measured with the singleexhalation method. A positive response to both bronchoconstrictor agen…

AdultMalePulmonary and Respiratory MedicineAllergyNitric OxideCritical Care and Intensive Care MedicineNitric oxidechemistry.chemical_compoundmedicineHumansExpirationAsthmabusiness.industryRespirationRhinitis Allergic Seasonalmedicine.diseaseAdenosine Monophosphaterespiratory tract diseasesCross-Sectional Studiesmedicine.anatomical_structurechemistryExhaled nitric oxideImmunologyFemaleBronchoconstrictionMethacholineBronchial Hyperreactivitymedicine.symptomCardiology and Cardiovascular Medicinebusinessmedicine.drugRespiratory tractChest
researchProduct

Serum Levels of Soluble CD23 in Patients with Asthma or Rhinitis Monosensitive to Parietaria. Its Relation to Total Serum IgE levels and Eosinophil C…

1999

The diagnostic value for allergies of the low affinity IgE receptor and its soluble circulating fragment (sCD23) remains unclear. In particular, little is know about seasonal influences on serum sCD23 levels in subjects with pollen allergy. In the present study, to gain insight into pathophysiological role of sCD23, we have analyzed, in blood from patients allergic to Parietaria sCD23, IgE, and eosinophil cationic protein (ECP) serum levels. IgE were assessed as atopy markers and ECP as an inflammation marker. Patients were studied during and out of pollen season, and results were compared to those obtained in nonallergic subjects. The study population included 42 nonsmoking outpatients, li…

AdultMalePulmonary and Respiratory MedicineAllergyParietariaAdolescentImmunoglobulin EAtopyRibonucleasesHumansImmunology and AllergyMedicinePlant ProteinsAsthmaEosinophil cationic proteinbiologyReceptors IgEbusiness.industryCD23Rhinitis Allergic SeasonalBlood ProteinsGeneral MedicineAllergensEosinophil Granule ProteinsImmunoglobulin EMiddle Agedmedicine.diseasebiology.organism_classificationAsthmaSolubilityImmunologybiology.proteinPollenPopulation studyFemaleImmunizationInflammation MediatorsbusinessAllergy and Asthma Proceedings
researchProduct

The Lack of the Bronchoprotective and Not the Bronchodilatory Ability of Deep Inspiration Is Associated with Airway Hyperresponsiveness

2001

In healthy subjects, deep inspiration (DI) acts both as a bronchodilator and a bronchoprotector. The latter is impaired in asthmatics. We have now evaluated whether the lack of bronchoprotection is related to bronchial hyperresponsiveness (BHR), and whether the bronchodilatory effect is also lost in asthmatics. Ten healthy subjects (PC20 > 75 mg/ml), 12 asthmatics with moderate to severe BHR (PC20 < 1 mg/ml), 14 asthmatics with mild to borderline BHR (1 < PC20 < 25 mg/ml), and 10 rhinitics with mild to borderline BHR (1 < PC20 < 25 mg/ml) underwent single-dose methacholine provocations inducing at least 20% reduction in FEV1 after 20 min of DI inhibition. To measure the bronchodilatory effe…

AdultMalePulmonary and Respiratory MedicineSpirometryRhinitis Allergic Perennialmedicine.drug_classBronchoconstrictionSettore MED/10 - Malattie Dell'Apparato RespiratorioCritical Care and Intensive Care MedicineBronchial Provocation TestsFEV1/FVC ratioReference ValuesRisk FactorsForced Expiratory VolumeBronchodilatormedicineHumansReference ValueMethacholine ChlorideAsthmaBronchusmedicine.diagnostic_testbusiness.industryMiddle Agedrespiratory systemmedicine.diseaseAsthmarespiratory tract diseasesBronchial Provocation TestBronchodilatationmedicine.anatomical_structureInhalationBronchial hyperresponsivenessAnesthesiaFemaleMethacholineBronchial HyperreactivitybusinessHumancirculatory and respiratory physiologymedicine.drugAmerican Journal of Respiratory and Critical Care Medicine
researchProduct

Effect of Salmeterol on Seasonal Changes in Airway Responsiveness and Exhaled Nitric Oxide in Pollen-Sensitive Asthmatic Subjects

2002

Objective Using a model of natural allergen exposure, we examined the effect of regular treatment with salmeterol on allergen-induced changes in airway responsiveness and exhaled nitric oxide (ENO). Design Double-blind, randomized, parallel-group study. Setting Specialist allergy unit in a university hospital. Patients Asthmatic patients sensitized to pollen allergens were randomly allocated to monotherapy with salmeterol (n = 14) or placebo (n = 13). Interventions Salmeterol, 25 μg, and placebo inhalers, two puffs bid, for 6 weeks. Measurements Spirometry, the level of a provocative concentration of a substance (methacholine) causing a 20% fall in FEV 1 (PC 20 ), the PC 20 level for adenos…

AdultMalePulmonary and Respiratory MedicineSpirometrymedicine.medical_specialtyAdolescentmedicine.drug_classNitric OxideCritical Care and Intensive Care MedicinePlaceboDouble-Blind MethodForced Expiratory VolumeInternal medicineBronchodilatorAdministration InhalationmedicineHumansAlbuterolExpirationSalmeterol XinafoateAsthmamedicine.diagnostic_testbusiness.industryAirway ResistanceRhinitis Allergic SeasonalMiddle Agedrespiratory systemmedicine.diseaseAdenosine MonophosphateAsthmarespiratory tract diseasesEndocrinologyBreath TestsExhaled nitric oxideFemaleMethacholineSeasonsSalmeterolCardiology and Cardiovascular Medicinebusinessmedicine.drugChest
researchProduct

Relationship between specific serum IGE to Ascaris lumbricoides and onset of respiratory symptoms in Bangladesh immigrants

2006

The role of helminths in asthma and/or rhinitis and in allergic sensitization is still unclear. We assessed the relationship between Ascaris-specific IgE, respiratory symptoms and allergic sensitization in Bangladesh immigrants. 246 individuals were examined from 1996 to 2001. Serum total IgE, Ascaris IgE, specific IgE to inhalant allergens, skin prick tests (SPT) and parasitological evaluation of the stool were performed. Total serum IgE were significantly higher in Ascaris-IgE positive (&gt; 0.35 kU/L) individuals (806.5 [409.0–1436.0] kU/L vs. 207.0 [127.0–332.5] kU/L; P &lt; 0.0001) and in subjects with respiratory symptoms (413.0 [239.0–1096.0] kU/L vs. 259.5 [147.0–387.0] kU/L), ( P …

AdultMaleSettore MED/09 - Medicina InternaRhinitis Allergic Perennial030231 tropical medicineImmunologyAntibodies HelminthImmunoglobulin ESerum ige030308 mycology & parasitologyspecific serum IgEAllergic sensitization03 medical and health sciences0302 clinical medicineAir PollutionImmunology and AllergyMedicineAnimalsHumansRespiratory systemAscaris lumbricoidesAsthmaSkin TestsPharmacology0303 health sciencesFamily Characteristicsbiologybusiness.industryAscarisBangladesh immigrants.specific serum IgE; Ascaris lumbricoides; Bangladesh immigrants.Rhinitis Allergic SeasonalHygieneEmigration and ImmigrationImmunoglobulin Ebiology.organism_classificationmedicine.diseaseAsthmaLogistic ModelsImmunologybiology.proteinAscaris lumbricoideFemaleAntibodyAscaris lumbricoidesbusiness
researchProduct

Determinants of bronchial hyperresponsiveness in subjects with rhinitis.

2005

Subjects with rhinitis but without asthma may have coexisting bronchial hyperresponsiveness, although the reasons for this are uncertain. To evaluate the factors that determine BHR in rhinitis we examined 410 patients with symptomatic rhinitis with forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) ≥ 80% of the predicted value. In all subjects a skin prick test (SPT) was performed, a determination of total serum IgE and an eosinophils count in the blood. Of the 410 subjects we found that 161 (39.3%) exhibited a methacholine PD20 of 800 mg or less (Group A), whereas 249 (60.7%) had a methacholine PD20 more of 800 mg (Group B). Despite the matched mean values for FEV…

AdultMaleVital capacitymedicine.medical_specialtyImmunologyVital CapacityGastroenterologyGroup B03 medical and health sciencesFEV1/FVC ratioLeukocyte Count0302 clinical medicineInternal medicineForced Expiratory VolumemedicineImmunology and AllergyHumansLife StyleBRONCHIAL HYPERRESPONSIVENESS; RHINITISAsthmaRhinitisSkin TestsPharmacologybusiness.industryRhinitis Allergic SeasonalPassive smokeImmunoglobulin Emedicine.diseaseRespiratory Function TestsEosinophilsBronchial hyperresponsivenessSpirometry030220 oncology & carcinogenesisBRONCHIAL HYPERRESPONSIVENESSMethacholineFemaleGeometric meanBronchial Hyperreactivitybusiness030215 immunologymedicine.drug
researchProduct

Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbi…

2008

Summary Background The treatment of allergic asthma by specific immunotherapy (SIT) is hampered by potential side-effects. Objective The aim of this study was to study the effect of omalizumab, a monoclonal anti-IgE antibody, in combination with SIT in patients with seasonal allergic rhinoconjunctivitis (SAR) and co-morbid seasonal allergic asthma (SAA) incompletely controlled by conventional pharmacotherapy. Methods A randomized, double-blind, placebo-controlled, multi-centre trial was performed to assess the efficacy and safety of omalizumab (Xolair®) vs. placebo in combination with depigmented SIT (Depigoid®) during the grass pollen season. Omalizumab or placebo was started 2 weeks befor…

AdultMalemedicine.medical_specialtyAdolescentCombination therapyImmunologyOmalizumabOmalizumabAntibodies Monoclonal HumanizedPlacebolaw.inventionYoung AdultPharmacotherapyDouble-Blind MethodRandomized controlled triallawForced Expiratory VolumeInternal medicineAnti-Allergic AgentsmedicineClinical endpointHumansImmunology and AllergyChildConjunctivitis AllergicAsthmaPlant Extractsbusiness.industryAntibodies MonoclonalRhinitis Allergic SeasonalAntigens PlantMiddle Agedmedicine.diseaseCombined Modality TherapyAsthmaAntibodies Anti-IdiotypicRespiratory Function TestsTreatment OutcomeDesensitization ImmunologicAsthma Control QuestionnaireQuality of LifePhysical therapyPollenFemalebusinessmedicine.drugClinical &amp; Experimental Allergy
researchProduct

Simultaneous sodium lauryl sulphate testing improves the diagnostic validity of allergic patch tests. Results from a prospective multicentre study of…

2005

Summary Background  There is evidence that a higher skin susceptibility may induce nonspecific erythematous or weak positive reactions to contact allergens in patch testing. Objectives  To evaluate whether simultaneous application of sodium lauryl sulphate (SLS) along with diagnostic patch tests with contact allergens can provide information regarding skin irritability which may help to discriminate allergic from nonspecific irritant reactions to contact allergens. Methods  Between July 2001 and June 2003, this prospective study collected patch test data of 5971 patients from 19 centres in Germany and Austria in the Information Network of Departments of Dermatology (IVDK). In addition to co…

AdultMalemedicine.medical_specialtyAllergyPathologyErythemaCocamidopropyl betaineDermatologymedicine.disease_causeDermatitis ContactDermatitis AtopicDiagnosis Differential030207 dermatology & venereal diseases03 medical and health sciencesBenzalkonium chloridechemistry.chemical_compound0302 clinical medicineAllergenPredictive Value of TestsMedicineHumansProspective StudiesDiagnostic Errorsintegumentary systembusiness.industryPatch testSodium Dodecyl SulfateAllergensPatch Testsmedicine.diseaseDermatology3. Good healthchemistryDermatitis OccupationalErythema030220 oncology & carcinogenesisDermatitis Allergic ContactFemalemedicine.symptomIrritationbusinessContact dermatitismedicine.drugThe British journal of dermatology
researchProduct

Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens.

1998

The efficacy and tolerance of short-term immunotherapy (STI) by seven preseasonal injections of tree-pollen allergens (ALK7 Fruhbluhermischung) was investigated in a double-blind, placebo-controlled, multicenter study with 111 rhinoconjunctivitis patients. Nasal and bronchial symptoms simultaneously analyzed, and nasal symptoms as a single end point, but not the overall score of nasal, bronchial, and conjunctival symptoms, showed a significantly lower increase with STI during birch-pollen exposure (both P=0.033, n=105, Mann-Whitney U-test). However, a selective analysis with patients from centers with high recruitment figures (n> or =10 patients, n=29 STI, n=32 placebo) showed a significant…

AdultMalemedicine.medical_specialtyAllergyTime FactorsAdolescentmedicine.medical_treatmentImmunologyPlaceboImmunoglobulin Emedicine.disease_causeGastroenterologyInjectionsTreesAllergenRibonucleasesDouble-Blind MethodInternal medicineImmunopathologyotorhinolaryngologic diseasesImmunology and AllergyMedicineHumansDesensitization (medicine)Conjunctivitis AllergicSkin TestsEosinophil cationic proteinbiologybusiness.industryRhinitis Allergic SeasonalBlood Proteinsrespiratory systemAllergensEosinophil Granule ProteinsImmunoglobulin EMiddle Agedmedicine.diseaseClinical trialTreatment OutcomeDesensitization ImmunologicImmunoglobulin GImmunologybiology.proteinPollenFemalebusinessAllergy
researchProduct

Late reactions to patch test preparations with reduced concentrations of p-phenylenediamine : a multicentre investigation of the German Contact Derma…

2011

Background. p-Phenylenediamine (PPD) 1% in petrolatum has been shown in a prospective study to elicit late reactions in 1.5% of routine patch tests, which may be indicative of patch test sensitization. Objectives. To assess the frequency of late reactions to reduced PPD patch test concentrations. Methods. In 1838 patients, PPD was tested at three concentrations (0.5% pet., group I; 0.4% pet., group II; and 0.35% pet., group III). Patch tests were read on D1 (D2) to D3 (D4); additional late readings were performed on D7, D14, and D21. Patients who were not able to return for all scheduled late readings were telephoned on D7, D14, and D21, and questioned about a reaction at the patch test sit…

AdultMalemedicine.medical_specialtyAllergyTime FactorsMedizinDermatologyPhenylenediaminesGastroenterology030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compoundYoung Adult0302 clinical medicineImmunopathologyInternal medicineImmunology and AllergyMedicineHumans030212 general & internal medicineProspective cohort studySensitizationbusiness.industryPatch testp-PhenylenediamineMiddle AgedPatch Testsmedicine.disease3. Good healthSurgerymedicine.anatomical_structurechemistryPatch test sensitizationDermatitis Allergic ContactFemalebusinessContact dermatitis
researchProduct